Potassium calcium-activated channel subfamily M alpha 1 mRNA with alternative 3′ untranslated regions (KCNMA1 3′UTR)

Potassium calcium-activated channel subfamily M alpha 1 (KCNMA1) encodes the alpha subunit of the large-conductance calcium-activated potassium (BK) channel, which is essential for regulating neuronal excitability and smooth muscle tone (UniProt P13255). The KCNMA1 transcript undergoes extensive alternative polyadenylation (APA), resulting in multiple 3′ untranslated region (3′UTR) isoforms that vary in length and regulatory content (PubMed: 28213110). These specific 3′UTRs contain binding sites for microRNAs and RNA-binding proteins that dictate mRNA stability, localization, and translation efficiency (PubMed: 23933513). Dysregulation of KCNMA1 expression due to 3′UTR-mediated instability or mutations is linked to neurological disorders, including generalized epilepsy and paroxysmal dyskinesia (GEPD) (NCBI Gene: 3777). Targeting specific KCNMA1 mRNA 3′UTR isoforms with antisense oligonucleotides (ASOs) or RNA interference represents a precision medicine approach to modulate channel density in patients with gain-of-function or loss-of-function mutations (PubMed: 31511361). This strategy allows for the fine-tuning of protein abundance, bypassing the limitations of traditional small-molecule channel modulators.

Other names

BK channel mRNASlo1 mRNAKCa1.1 mRNAKCNMA1 alternative 3′UTR isoformsKCNMA1 APA variantsMaxiK mRNA

Modulation of mRNA stability and translation efficiency through sequence-specific binding to 3′UTR regulatory elements to alter protein expression levels.